Recruiting

Maternal Cancer

Sponsor:

The Cooper Health System

Code:

NCT02749474

Conditions

Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.

Conditions

Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related

Study ID

NCT02749474

Start date

Jul, 2003

Status verified date

Jun, 2024

Completion date

Jul, 2025

Anticipated

Primary completion date

Jul, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Any pregnant woman diagnosed with cancer within 6 weeks before her last menstrual period or 6 months after her end of pregnancy either by delivery or miscarriage.

Exclusion Criteria:

  • Women diagnosed with cancer more than 6 months after the end of a pregnancy.

Study Design

Enrollment

400 participants

Anticipated

Interventions and Outcome Measures

Arms

Pregnant women diagnosed with cancer

Any pregnant woman diagnosed with any cancer within 6 weeks prior to their last menstrual period, or up to 6 months after the end of their pregnancy can be enrolled.

Primary outcome measure

  • Neonatal Developmental Quotient [ Time Frame: Yearly from 3 months to 12 years of age ]

Central Contacts and Locations

Central contacts

Locations

Cooper University Hospital

Recruiting

Camden, New Jersey, United States, 08103

Contacts

More Information

Sponsor

The Cooper Health System

Last update posted

Jun 10, 2024

Last verified

Jun, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Cooper Health System on 2024-06-10.